Based on the above results, we concluded that DDX3 loss activates Snail/Slug/E-cadherin and β-catenin signals through the MAPK pathway, which promotes EMT, thus leading to CRC progression (Figure 7B). Here, DDX3X is linked to colorectal carcinoma.